Actinium News

Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Centessa Pharmaceuticals (CNTA)

TipRanksApr 1 10:20 ET

Actinium Pharma Analyst Ratings

BenzingaApr 1 08:21 ET

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Kiora Pharmaceuticals (KPRX) and Actinium Pharmaceuticals (ATNM)

TipRanksMar 28 07:30 ET

Actinium Pharma Analyst Ratings

BenzingaMar 26 12:13 ET

Analysts Offer Insights on Healthcare Companies: Precision BioSciences (DTIL) and Actinium Pharmaceuticals (ATNM)

TipRanksMar 20 12:50 ET

Maxim Adjusts Actinium Pharmaceuticals' Price Target to $30 From $20, Maintains Buy Rating

MT NewswiresMar 19 13:14 ET

Maxim Group Maintains Buy on Actinium Pharma, Raises Price Target to $30

BenzingaMar 19 12:59 ET

Actinium Pharma Analyst Ratings

BenzingaMar 19 11:18 ET

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

BenzingaMar 19 11:19 ET

Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and P3 Health Partners (PIII)

TipRanksMar 14 09:00 ET

Actinium Pharma Analyst Ratings

BenzingaMar 11 10:36 ET

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

BenzingaMar 11 10:37 ET

Actinium Pharma Analyst Ratings

BenzingaDec 11, 2023 11:51 ET

B. Riley Adjusts Price Target on Actinium Pharmaceuticals to $16 From $20, Maintains Buy Rating

MT NewswiresDec 11, 2023 08:49 ET

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Actinium Pharmaceuticals (ATNM) and QuidelOrtho (QDEL)

TipRanksNov 2, 2023 12:25 ET

Actinium Pharma Analyst Ratings

BenzingaOct 3, 2023 13:13 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Inovio Pharmaceuticals (INO)

TipRanksSep 7, 2023 12:20 ET

Actinium Pharma Analyst Ratings

BenzingaSep 7, 2023 12:04 ET

HSBC Initiates Coverage On Actinium Pharma With Buy Rating, Announces Price Target of $11.6

BenzingaSep 6, 2023 05:06 ET

Actinium Pharma Analyst Ratings

BenzingaSep 6, 2023 05:01 ET